TP53 and lung carcinoma: Regarding lung cancer, FX exhibited growth inhibitory effects in several lung carcinoma cell lines by up-regulation of the proapoptotic genes PUMA (p53 up-regulated modulator of apoptosis) and Fas, as well as suppression of Bcl-2 levels [361].